Jane Street Group, LLC Syndax Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 133,541 shares of SNDX stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,541

Previous 153,311 12.9%

Holding current value

$2.15 Million

Previous $3.15 Million 18.33%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.93 - $24.81 $354,476 - $490,493	-19,770 Reduced 12.9%	133,541 $2.57 Million
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $748,716 - $946,437	39,783 Added 35.04%	153,311 $3.15 Million
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $127,366 - $158,771	6,462 Added 6.04%	113,528 $2.7 Million
Q4 2023 Feb 14, 2024	SELL	$11.39 - $21.67 $490,510 - $933,218	-43,065 Reduced 28.68%	107,066 $2.31 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $1.58 Million - $2.36 Million	108,546 Added 261.02%	150,131 $2.18 Million
Q2 2023 Aug 14, 2023	SELL	$19.35 - $22.31 $421,868 - $486,402	-21,802 Reduced 34.4%	41,585 $870,000
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $924,059 - $1.3 Million	44,727 Added 239.69%	63,387 $1.34 Million
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $385,142 - $489,638	18,660 New	18,660 $474,000
Q1 2022 May 17, 2022	SELL	$14.84 - $22.15 $323,185 - $482,382	-21,778 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$15.23 - $22.47 $331,678 - $489,351	21,778 New	21,778 $477,000
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $255,422 - $479,250	-19,033 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$19.28 - $24.59 $651,914 - $831,461	-33,813 Reduced 63.98%	19,033 $425,000
Q4 2020 Feb 17, 2021	BUY	$15.1 - $26.44 $797,974 - $1.4 Million	52,846 New	52,846 $1.18 Million
Q3 2020 Nov 17, 2020	SELL	$13.39 - $17.48 $489,739 - $639,331	-36,575 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$8.94 - $20.98 $326,980 - $767,343	36,575 New	36,575 $541,000

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $910M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Syndax Pharmaceuticals Inc Transaction History